Advanced Computational Biology Methods Identify Molecular Switches for Malignancy in an EGF Mouse Model of Liver Cancer

• Philip Stegmaier,

  Affiliation BIOBASE GmbH, Wolfenbuettel, Germany

  ⨯
• Nico Voss,

  Affiliation BIOBASE GmbH, Wolfenbuettel, Germany

  ⨯
• Tatiana Meier,

  Affiliations Department Molecular Medicine and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany, Centre for Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany

  ⨯
• Alexander Kel,

  Affiliations BIOBASE GmbH, Wolfenbuettel, Germany, GeneXplain GmbH, Wolfenbuettel, Germany, Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia

  ⨯
• Edgar Wingender,

  Affiliations BIOBASE GmbH, Wolfenbuettel, Germany, GeneXplain GmbH, Wolfenbuettel, Germany, Department of Bioinformatics, University of Goettingen, Goettingen, Germany

  ⨯
• Juergen Borlak

  * E-mail: juergen.borlak@item.fraunhofer.de

  Affiliations Department Molecular Medicine and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany, Centre for Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany

  ⨯